A Two-arm, Open-label, Single-sequence, Multiple-dose, Cross-over Phase 1 Study to Evaluate the Pharmacokinetic Interaction and Safety of CTL0901 and CTL0902 Compared to Coadministration in Healthy Adult Volunteers
Latest Information Update: 29 Dec 2021